Showing results (31-40 of 255) with videos related to

Sort By:
Pageof 26
Clinical Pharmacokinetics|November 1, 1985
Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medicationR Riva, M Contin, F Albani, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsyM Contin, R Riva, F Albani, et al.
Neurology|July 1, 1994
Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's diseaseM Contin, R Riva, P Martinelli, et al.
Therapeutic Drug Monitoring|January 22, 2002
Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approachM Contin, R Riva, P Martinelli, et al.
Clinical Neuropharmacology|January 8, 2000
Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's diseaseM Contin, R Riva, P Martinelli, et al.
Clinical Neuropharmacology|April 1, 1991
Combined levodopa-anticholinergic therapy in the treatment of Parkinson's disease. Effect on levodopa bioavailabilityM Contin, R Riva, P Martinelli, et al.
Parkinsonism & Related Disorders|January 1, 1996
Postural stability in Parkinson's disease: the effects of disease severity and acute levodopa dosingM Contin, R Riva, A Baruzzi, et al.
Neurology|October 22, 1998
A levodopa kinetic-dynamic study of the rate of progression in Parkinson's diseaseM Contin, R Riva, P Martinelli, et al.
Neurology|February 1, 1993
Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's diseaseM Contin, R Riva, P Martinelli, et al.
Therapeutic Drug Monitoring|June 1, 1983
Valproic acid free fraction in epileptic children under chronic monotherapyR Riva, F Albani, E Franzoni, et al.
Pageof 26